Intranasal immunization against influenza.
Nasalflu is a novel influenza subunit vaccine, which is administered by the intranasal route using a spray device. Nasalflu is based on the virosomal concept which is registered in the EU as Epaxal Berna, a vaccine against Hepatitis A, and Inflexal Berna V, a subunit influenza vaccine. The virosome is a carrier system which delivers antigens to cells and is able to induce both B- and T-cell immunity. When virosomal vaccines are given parenterally, an immune response is elicited fast and sufficiently.
Berna Biotech Ltd., Rehhagstrasse 79, CH-3018 Bern, Switzerland. marlyse.guidolin@bernabiotech.com
Reinhard
R
Glück
D000276:Adjuvants, Immunologic; D000281:Administration, Intranasal; D001427:Bacterial Toxins / Q000276:immunology; D004926:Escherichia coli; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control*
D000276:Adjuvants, Immunologic; D001427:Bacterial Toxins; D007252:Influenza Vaccines